Delivery Order SPE2DB24D6039-SPE2DB25FLELH
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packaging) under a firm fixed price contract valued at $2,466.80. This delivery order, which was not set-aside, is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction for pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,822.55. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,864.20 on August 1, 2025, for the supply of Cipro 500 mg tablets in quantities of 100. This competitive award, executed under firm fixed-price terms with no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cipro 500 mg tablets (100-count units) with a ceiling value of $1,175.85. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside procurement issued to the prime contractor at its Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100 units, with a ceiling value of $1,403.89. This contract utilizes a firm fixed price model with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ciprofloxacin HCL 250 mg tablets (100-count units) with a ceiling value of $1,069.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The...
- The Defense Logistics Agency awarded a $3,362.37 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count units). This firm fixed-price contract, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The antibiotic pharmaceutical product supports federal medical procurement requirements for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4,563,981,943 units of Ciprofloxacin HCL 500 mg tablets. The $2,506.82 firm fixed price contract has a performance period through March 18, 2024 and was not set aside for any specific business type. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and holds an indefinite delivery contract (IDC) with DLA...
- SPE2DB24D6039Indefinite Delivery Contract
- SPE2DB24D6039-SPE2DB25FLELHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $4,248.57. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order exemplifies the routine pharmaceutical procurement activities executed under this expansive framework agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/7/25 |